Skip to main content

Table 3 Risk of neurological conditions among active duty DWH-CG Cohort responders reporting ever vs. never exposure to crude oil inhalation, 2010-2015

From: Risk of longer-term neurological conditions in the Deepwater Horizon Oil Spill Coast Guard Cohort Study – Five years of follow-up

 

Oil inhalation ever (N=1068)

Oil inhalation never (N=2424)

 

Condition (ICD-9 code)

N

Person Years

N

Person Years

HRa (95% CI)

Migraine (346)

37

4711

65

10426

1.41 (0.93-2.13)

 Migraine with aura (346.0)

11

4874

14

10787

2.22 (0.98-5.01)

 Migraine, unspecified (346.9)

26

4762

60

10490

1.05 (0.66-1.68)

Migraine excl. menstrual migraine and persistent migraine aura with cerebral infarction (346.1-346.3, 346.5, 346.7-346.9)

34

4725

60

10454

1.38 (0.90-2.11)

Headache (784.0)

62

4616

100

10259

1.47 (1.07-2.04)

Other headache syndromes (339)

21

4831

30

10731

1.83 (1.03-3.25)

Headaches/migraines combined (339, 346, 784.0)

90

4444

157

9906

1.41 (1.08-1.84)

Headaches/migraines combined excl. menstrual migraine and persistent migraine aura with cerebral infarction

(339, 346.1-346.3, 346.5, 346.7-346.9, 784.0)

88

4456

156

9922

1.39 (1.06-1.81)

Mononeuritis of upper limb and mononeuritis multiplex (354)

27

4805

42

10675

1.71 (1.04-2.83)

 Carpal tunnel syndrome (354.0)

16

4851

28

10727

1.51 (0.80-2.84)

Mononeuritis of lower limb (355)

15

4871

30

10761

1.22 (0.65-2.30)

Visual disturbances (368)

18

4814

38

10674

1.11 (0.62-1.96)

Hearing loss (389)

52

4679

123

10383

1.05 (0.75-1.46)

Tinnitus (388.3)

37

4825

50

10680

1.91 (1.23-2.96)

Syncope and collapse (780.2)

13

4858

29

10699

1.12 (0.57-2.19)b

Dizziness and giddiness (780.4)

20

4829

68

10536

0.73 (0.44-1.22)

Abnormality of gait (781.2)

13

4860

24

10736

1.17 (0.59-2.32)

Disturbance of skin sensation (782.0)

31

4804

61

10598

1.13 (0.73-1.76)

  1. aModels adjusted for age, sex, race, and smoking; b Because of the proportionality of hazards assumption violation for syncope and collapse during 2010-2015 (Schoenfeld p<0.05), results from sub-period analyses were: 2010-2012: Noil inhal ever=3, Noil inhal never=17, HR=0.41, 95% CI: 0.12-1.42 and 2013-2015: Noil inhal ever =10, Noil inhal never =12, HR 2.35, 95% CI: 0.98-5.63.
  2. Bold indicative of statistical significance